Evidence map›Paper›PMID 41369823›Full record

ArticleJournal of assisted reproduction and genetics2026

Novel INSL3 variants cause male infertility with cryptorchidism.

Chunjia Wei, Wenqing Lu, Yong Li, Yaoqiong Liang, Lanlan Meng, Chen Tan, Ge Lin, Yue-Qiu Tan, Qianjun Zhang, Chaofeng Tu and 1 more

Abstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chunjia Wei *NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China.
Wenqing Lu *NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China.
Yong LiNHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China.
Yaoqiong LiangNHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China.
Lanlan MengNHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China.
Chen TanNHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China.
Ge LinNHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China.
Yue-Qiu TanNHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China.
Qianjun ZhangNHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China.
Chaofeng TuNHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China. 222041@csu.edu.cn.ORCID http://orcid.org/0000-0001-5682-8948
Juan DuNHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China. tandujuan@csu.edu.cn.

Funding

National Natural Science Foundation of China 82471652Outstanding Youth Scientist Foundation of Hunan Province 2023JJ20080Science and Technology Program of Hunan Province 2024RC3027
6 · The paper itself

Abstract

purposeCryptorchidism is one of the most prevalent male congenital abnormalities, affecting 1.6%-9% of newborn males, and it poses substantial risks to male fertility. INSL3 and its receptor RXFP2 play a major role in the first phase of the biphasic testicular descent process. The genetic etiology of cryptorchidism has long remained controversial, and the association between INSL3 gene mutations and cryptorchidism still requires robust evidence to substantiate. This study aims to clarify that the novel homozygous frameshift variants of INSL3 are the genetic cause of cryptorchidism in patients.

methodsWhole-exome sequencing (WES) and Sanger sequencing were performed on peripheral blood samples collected from two infertile patients with cryptorchidism. The AlphaFold database and PyMOL software were used to predict the 3D structure of INSL3 protein. In vitro analyses were performed to determine the effects of the identified INSL3 variants on protein function.

resultsWe identified two novel homozygous frameshift variants (NM_005543:c.176_182delCGACCGG:p.Ala59GlufsTer66 for F1-II-1; c.148dupC:p.Arg50ProfsTer16 for F2-II-1) in INSL3. Both variants were absent or rare from public databases. Prediction of 3D protein structure indicated that INSL3 variants caused alterations in the spatial conformation of the protein. In vitro experiments further confirmed that these variants led to the production of truncated proteins, which potentially disrupt the function of INSL3 and its interaction with RXFP2.

conclusionIn this study, two novel homozygous frameshift variants in INSL3 were detected in two patients with cryptorchidism. These findings strengthen the link between INSL3 mutations and male infertility caused by cryptorchidism.

Indexed as

CryptorchidismInfertility, MaleInsulinProteinsAdultExome SequencingFrameshift MutationHomozygoteHumansMaleReceptors, G-Protein-CoupledInsulinLeydig insulin-like proteinProteinsReceptors, G-Protein-CoupledRXFP2 protein, humanCryptorchidismINSL3Male infertilityMutation

Identifiers

PMID41369823
PMCPMC12901795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.